Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE): A systematic review

Brandon L. Adler, Aimee E. Krausz, Aurelia Minuti, Jonathan I. Silverberg, Hadar Lev-Tov

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background Current knowledge of angiolymphoid hyperplasia with eosinophilia (ALHE) derives from retrospective reports and case series, leading to a nonevidence-based treatment approach. Objective We sought to systematically review the literature relating to cutaneous ALHE to estimate its epidemiology and treatment outcomes. Methods A literature search of PubMed, EMBASE, Web of Science, and Google Scholar was conducted. Articles detailing cases of histologically confirmed cutaneous ALHE were included. Results In all, 416 studies were included in the review, representing 908 patients. There was no sex predominance among patients with ALHE. Mean age at presentation was 37.6 years. There was a significant association between presence of multiple lesions and pruritus, along with bleeding. Surgical excision was the most commonly reported treatment for ALHE. Treatment failure was lowest for excision and pulsed dye laser. Mean disease-free survival after excision was 4.2 years. There were higher rates of recurrence postexcision with earlier age of onset, longer duration of disease, multiple lesions, bilateral lesions, pruritus, pain, and bleeding. Limitations Potential for publication bias is a limitation. Conclusions Surgical excision appears to be the most effective treatment for ALHE, albeit suboptimal. Pulsed dye and other lasers may be effective treatment options. More studies are needed to improve the treatment of ALHE.

Original languageEnglish (US)
Pages (from-to)506-512
Number of pages7
JournalJournal of the American Academy of Dermatology
Volume74
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Angiolymphoid Hyperplasia with Eosinophilia
Epidemiology
Dye Lasers
Pruritus
Therapeutics
Hemorrhage
Publication Bias
Skin
Treatment Failure
Age of Onset
PubMed
Disease-Free Survival
Recurrence
Pain

Keywords

  • angiolymphoid hyperplasia with eosinophilia
  • epidemiology
  • excision
  • histiocytoid hemangioma
  • pseudopyogenic granuloma
  • surgery

ASJC Scopus subject areas

  • Dermatology

Cite this

Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE) : A systematic review. / Adler, Brandon L.; Krausz, Aimee E.; Minuti, Aurelia; Silverberg, Jonathan I.; Lev-Tov, Hadar.

In: Journal of the American Academy of Dermatology, Vol. 74, No. 3, 01.03.2016, p. 506-512.

Research output: Contribution to journalArticle

Adler, Brandon L. ; Krausz, Aimee E. ; Minuti, Aurelia ; Silverberg, Jonathan I. ; Lev-Tov, Hadar. / Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE) : A systematic review. In: Journal of the American Academy of Dermatology. 2016 ; Vol. 74, No. 3. pp. 506-512.
@article{15ef087ace884b04a9ba3c9784e06562,
title = "Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE): A systematic review",
abstract = "Background Current knowledge of angiolymphoid hyperplasia with eosinophilia (ALHE) derives from retrospective reports and case series, leading to a nonevidence-based treatment approach. Objective We sought to systematically review the literature relating to cutaneous ALHE to estimate its epidemiology and treatment outcomes. Methods A literature search of PubMed, EMBASE, Web of Science, and Google Scholar was conducted. Articles detailing cases of histologically confirmed cutaneous ALHE were included. Results In all, 416 studies were included in the review, representing 908 patients. There was no sex predominance among patients with ALHE. Mean age at presentation was 37.6 years. There was a significant association between presence of multiple lesions and pruritus, along with bleeding. Surgical excision was the most commonly reported treatment for ALHE. Treatment failure was lowest for excision and pulsed dye laser. Mean disease-free survival after excision was 4.2 years. There were higher rates of recurrence postexcision with earlier age of onset, longer duration of disease, multiple lesions, bilateral lesions, pruritus, pain, and bleeding. Limitations Potential for publication bias is a limitation. Conclusions Surgical excision appears to be the most effective treatment for ALHE, albeit suboptimal. Pulsed dye and other lasers may be effective treatment options. More studies are needed to improve the treatment of ALHE.",
keywords = "angiolymphoid hyperplasia with eosinophilia, epidemiology, excision, histiocytoid hemangioma, pseudopyogenic granuloma, surgery",
author = "Adler, {Brandon L.} and Krausz, {Aimee E.} and Aurelia Minuti and Silverberg, {Jonathan I.} and Hadar Lev-Tov",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.jaad.2015.10.011",
language = "English (US)",
volume = "74",
pages = "506--512",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE)

T2 - A systematic review

AU - Adler, Brandon L.

AU - Krausz, Aimee E.

AU - Minuti, Aurelia

AU - Silverberg, Jonathan I.

AU - Lev-Tov, Hadar

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Background Current knowledge of angiolymphoid hyperplasia with eosinophilia (ALHE) derives from retrospective reports and case series, leading to a nonevidence-based treatment approach. Objective We sought to systematically review the literature relating to cutaneous ALHE to estimate its epidemiology and treatment outcomes. Methods A literature search of PubMed, EMBASE, Web of Science, and Google Scholar was conducted. Articles detailing cases of histologically confirmed cutaneous ALHE were included. Results In all, 416 studies were included in the review, representing 908 patients. There was no sex predominance among patients with ALHE. Mean age at presentation was 37.6 years. There was a significant association between presence of multiple lesions and pruritus, along with bleeding. Surgical excision was the most commonly reported treatment for ALHE. Treatment failure was lowest for excision and pulsed dye laser. Mean disease-free survival after excision was 4.2 years. There were higher rates of recurrence postexcision with earlier age of onset, longer duration of disease, multiple lesions, bilateral lesions, pruritus, pain, and bleeding. Limitations Potential for publication bias is a limitation. Conclusions Surgical excision appears to be the most effective treatment for ALHE, albeit suboptimal. Pulsed dye and other lasers may be effective treatment options. More studies are needed to improve the treatment of ALHE.

AB - Background Current knowledge of angiolymphoid hyperplasia with eosinophilia (ALHE) derives from retrospective reports and case series, leading to a nonevidence-based treatment approach. Objective We sought to systematically review the literature relating to cutaneous ALHE to estimate its epidemiology and treatment outcomes. Methods A literature search of PubMed, EMBASE, Web of Science, and Google Scholar was conducted. Articles detailing cases of histologically confirmed cutaneous ALHE were included. Results In all, 416 studies were included in the review, representing 908 patients. There was no sex predominance among patients with ALHE. Mean age at presentation was 37.6 years. There was a significant association between presence of multiple lesions and pruritus, along with bleeding. Surgical excision was the most commonly reported treatment for ALHE. Treatment failure was lowest for excision and pulsed dye laser. Mean disease-free survival after excision was 4.2 years. There were higher rates of recurrence postexcision with earlier age of onset, longer duration of disease, multiple lesions, bilateral lesions, pruritus, pain, and bleeding. Limitations Potential for publication bias is a limitation. Conclusions Surgical excision appears to be the most effective treatment for ALHE, albeit suboptimal. Pulsed dye and other lasers may be effective treatment options. More studies are needed to improve the treatment of ALHE.

KW - angiolymphoid hyperplasia with eosinophilia

KW - epidemiology

KW - excision

KW - histiocytoid hemangioma

KW - pseudopyogenic granuloma

KW - surgery

UR - http://www.scopus.com/inward/record.url?scp=84958151929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958151929&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2015.10.011

DO - 10.1016/j.jaad.2015.10.011

M3 - Article

C2 - 26685720

AN - SCOPUS:84958151929

VL - 74

SP - 506

EP - 512

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 3

ER -